Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Sapheon raises $5mm through the sale of convertible notes

Executive Summary

Sapheon Inc. has raised $5mm through the sale of convertible notes to 13 undisclosed investors. The company is developing a device that uses a catheter to deliver a medical adhesive to close varicose veins without the need for burning and harsh chemicals that traditional treatments rely upon. Sapheon raised over $5mm through its 2010 Series A venture round.

Deal Industry
  • Biotechnology
  • Medical Devices
  • Medical Devices
    • Biomaterials
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Convertible Debt
    • Private Placement

Related Companies